Мультимодальный подход при диагностике пациентов с токсоплазмозным хориретинитом

    1. Aggarwal R., Ringold S., Khanna D., et al. Epidemiology, diagnostic and classification criteria patients with ocular toxoplasmosis. 2015; 67:891–897.

    2. Choi W.Y., Nam H.W., Kwak N.H., Huh W., Kim Y.R., Kang M.W., et al. Clinical signs of human toxoplasmosis. J. Infect. Dis. 2017;175:1280–1282. 10.1086/593702

    3. Dodds E.M., Holland G.N., Stanford M.R., et al. Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Am. J. Ophthalmol. 2018;146:856–865.

    4. Gennari S.M., Lago E.G. Toxoplasmosis in humans and animals. Parasitology. 2012;139(11):1375– 1424. doi: 10.1017/S0031182012000765

    5. Hogan M.J., Kimura S.J., O’Connor G.R. Ocular toxoplasmosis. Arch. Ophthalmol. 2014;72:592– 600.

    6. Holland G.N., Lewis K.G. An update on current practices in the management of ocular toxoplasmosis. Am. J. Ophthalmol. 2016;134:102–114.

    7. Ozgonul C., Besirli C.G. Epidemiology and recent developments in the diagnosis and treatment of ocular toxoplasmosis. Ophthalmic. Res. 2017;57(1):1–12. doi:10.1159/000449169